Cargando…

Curcumin-1,2,3-Triazole Conjugation for Targeting the Cancer Apoptosis Machinery

The burden of neoplastic diseases is widely recognized as a severe cause of mortality. The clinical inadequacy of most anticancer therapeutics urgently prompted intense drug discovery efforts toward the identification of new chemical entities endowed with a potent and safe antitumor profile. In this...

Descripción completa

Detalles Bibliográficos
Autores principales: Seghetti, Francesca, Di Martino, Rita Maria Concetta, Catanzaro, Elena, Bisi, Alessandra, Gobbi, Silvia, Rampa, Angela, Canonico, Barbara, Montanari, Mariele, Krysko, Dmitri V., Papa, Stefano, Fimognari, Carmela, Belluti, Federica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7412087/
https://www.ncbi.nlm.nih.gov/pubmed/32635622
http://dx.doi.org/10.3390/molecules25133066
_version_ 1783568527366553600
author Seghetti, Francesca
Di Martino, Rita Maria Concetta
Catanzaro, Elena
Bisi, Alessandra
Gobbi, Silvia
Rampa, Angela
Canonico, Barbara
Montanari, Mariele
Krysko, Dmitri V.
Papa, Stefano
Fimognari, Carmela
Belluti, Federica
author_facet Seghetti, Francesca
Di Martino, Rita Maria Concetta
Catanzaro, Elena
Bisi, Alessandra
Gobbi, Silvia
Rampa, Angela
Canonico, Barbara
Montanari, Mariele
Krysko, Dmitri V.
Papa, Stefano
Fimognari, Carmela
Belluti, Federica
author_sort Seghetti, Francesca
collection PubMed
description The burden of neoplastic diseases is widely recognized as a severe cause of mortality. The clinical inadequacy of most anticancer therapeutics urgently prompted intense drug discovery efforts toward the identification of new chemical entities endowed with a potent and safe antitumor profile. In this scenario, targeting cancer cells apoptosis machinery has emerged as a relevant strategy, useful for tackling the emergence of drug resistance. On this basis, a small library of naturally inspired hybrid molecules was obtained by combining, through a click chemistry approach, “privileged” synthons such as curcumin scaffold and 1,2,3-triazole building block. Compound 1, bearing a para-fluoro phenyl moiety, showed low-micromolar potency against T acute lymphoblastic leukemia cell growth. More in-depth biologic studies demonstrated, for this analog, cell death-inducing properties associated with its capability to simultaneously activate both the receptor and the mitochondrial apoptosis cascades. This peculiar behavior offers promises for achieving an expanded anticancer effect, namely intense cytotoxic response coupled with reduced predisposition of chemoresistance insurgence. Altogether, this study allowed the identification of compound 1 as a lead compound worth to be progressed as an anticancer drug candidate.
format Online
Article
Text
id pubmed-7412087
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-74120872020-08-25 Curcumin-1,2,3-Triazole Conjugation for Targeting the Cancer Apoptosis Machinery Seghetti, Francesca Di Martino, Rita Maria Concetta Catanzaro, Elena Bisi, Alessandra Gobbi, Silvia Rampa, Angela Canonico, Barbara Montanari, Mariele Krysko, Dmitri V. Papa, Stefano Fimognari, Carmela Belluti, Federica Molecules Article The burden of neoplastic diseases is widely recognized as a severe cause of mortality. The clinical inadequacy of most anticancer therapeutics urgently prompted intense drug discovery efforts toward the identification of new chemical entities endowed with a potent and safe antitumor profile. In this scenario, targeting cancer cells apoptosis machinery has emerged as a relevant strategy, useful for tackling the emergence of drug resistance. On this basis, a small library of naturally inspired hybrid molecules was obtained by combining, through a click chemistry approach, “privileged” synthons such as curcumin scaffold and 1,2,3-triazole building block. Compound 1, bearing a para-fluoro phenyl moiety, showed low-micromolar potency against T acute lymphoblastic leukemia cell growth. More in-depth biologic studies demonstrated, for this analog, cell death-inducing properties associated with its capability to simultaneously activate both the receptor and the mitochondrial apoptosis cascades. This peculiar behavior offers promises for achieving an expanded anticancer effect, namely intense cytotoxic response coupled with reduced predisposition of chemoresistance insurgence. Altogether, this study allowed the identification of compound 1 as a lead compound worth to be progressed as an anticancer drug candidate. MDPI 2020-07-05 /pmc/articles/PMC7412087/ /pubmed/32635622 http://dx.doi.org/10.3390/molecules25133066 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Seghetti, Francesca
Di Martino, Rita Maria Concetta
Catanzaro, Elena
Bisi, Alessandra
Gobbi, Silvia
Rampa, Angela
Canonico, Barbara
Montanari, Mariele
Krysko, Dmitri V.
Papa, Stefano
Fimognari, Carmela
Belluti, Federica
Curcumin-1,2,3-Triazole Conjugation for Targeting the Cancer Apoptosis Machinery
title Curcumin-1,2,3-Triazole Conjugation for Targeting the Cancer Apoptosis Machinery
title_full Curcumin-1,2,3-Triazole Conjugation for Targeting the Cancer Apoptosis Machinery
title_fullStr Curcumin-1,2,3-Triazole Conjugation for Targeting the Cancer Apoptosis Machinery
title_full_unstemmed Curcumin-1,2,3-Triazole Conjugation for Targeting the Cancer Apoptosis Machinery
title_short Curcumin-1,2,3-Triazole Conjugation for Targeting the Cancer Apoptosis Machinery
title_sort curcumin-1,2,3-triazole conjugation for targeting the cancer apoptosis machinery
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7412087/
https://www.ncbi.nlm.nih.gov/pubmed/32635622
http://dx.doi.org/10.3390/molecules25133066
work_keys_str_mv AT seghettifrancesca curcumin123triazoleconjugationfortargetingthecancerapoptosismachinery
AT dimartinoritamariaconcetta curcumin123triazoleconjugationfortargetingthecancerapoptosismachinery
AT catanzaroelena curcumin123triazoleconjugationfortargetingthecancerapoptosismachinery
AT bisialessandra curcumin123triazoleconjugationfortargetingthecancerapoptosismachinery
AT gobbisilvia curcumin123triazoleconjugationfortargetingthecancerapoptosismachinery
AT rampaangela curcumin123triazoleconjugationfortargetingthecancerapoptosismachinery
AT canonicobarbara curcumin123triazoleconjugationfortargetingthecancerapoptosismachinery
AT montanarimariele curcumin123triazoleconjugationfortargetingthecancerapoptosismachinery
AT kryskodmitriv curcumin123triazoleconjugationfortargetingthecancerapoptosismachinery
AT papastefano curcumin123triazoleconjugationfortargetingthecancerapoptosismachinery
AT fimognaricarmela curcumin123triazoleconjugationfortargetingthecancerapoptosismachinery
AT bellutifederica curcumin123triazoleconjugationfortargetingthecancerapoptosismachinery